Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases.

about

Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases.

Item

http://www.wikidata.org/entity/Q45324037

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Infusions of Epstein-Barr viru ...... patients: report of two cases.

@en

Infusions of Epstein-Barr viru ...... patients: report of two cases.

@nl

type

Item

label

Infusions of Epstein-Barr viru ...... patients: report of two cases.

@en

Infusions of Epstein-Barr viru ...... patients: report of two cases.

@nl

prefLabel

Infusions of Epstein-Barr viru ...... patients: report of two cases.

@en

Infusions of Epstein-Barr viru ...... patients: report of two cases.

@nl

P1476

Infusions of Epstein-Barr viru ...... patients: report of two cases.

@en

P2093

Byung Ha Chung

http://www.w3.org/2001/XMLSchema#string

Chul-Woo Yang

http://www.w3.org/2001/XMLSchema#string

Hyun-Il Cho

http://www.w3.org/2001/XMLSchema#string

Hyun-Joo Lee

http://www.w3.org/2001/XMLSchema#string

Hyun-Jung Sohn

http://www.w3.org/2001/XMLSchema#string

Joo Hyun Oh

http://www.w3.org/2001/XMLSchema#string

Nayoun Kim

http://www.w3.org/2001/XMLSchema#string

Tai-Gyu Kim

http://www.w3.org/2001/XMLSchema#string

Young-Woo Jeon

http://www.w3.org/2001/XMLSchema#string

P2860

Epstein-Barr virus: 40 years on

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★).

Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.

Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.

Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma.

Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication.

P2888

s12185-017-2381-3

P31

scholarly article

P356

10.1007/S12185-017-2381-3

http://www.w3.org/2001/XMLSchema#string

P50

Seok-Goo Cho

P577

2017-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1093054585

http://www.w3.org/2001/XMLSchema#string

P698

29188583

http://www.w3.org/2001/XMLSchema#string

P921

Post-transplant lymphoproliferative disorder